title: Comment on AAN-EFNS guidelines on trigeminal neuralgia management.
authors.forename: H A G
authors.initials: HA
authors.lastname: Teive
authors.forename: E J
authors.initials: EJ
authors.lastname: Piovesan
authors.forename: P A
authors.initials: PA
authors.lastname: Kowacs
authors.forename: R P
authors.initials: RP
authors.lastname: Munhoz
authors.forename: L C
authors.initials: LC
authors.lastname: Werneck
mesh_terms: D000700:Analgesics / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017408:Guidelines as Topic; D006801:Humans; D014277:Trigeminal Neuralgia / Q000188:drug therapy*
chemical_list: D000700:Analgesics; D000927:Anticonvulsants; D019274:Botulinum Toxins, Type A